Artificial Intelligence3 years ago
Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets
Huadong Medicine (SZ.000963) and Insilico Medicine (“Insilico”), an end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the companies have entered into a co-development...